A detailed history of Ossiam transactions in Johnson & Johnson stock. As of the latest transaction made, Ossiam holds 6,839 shares of JNJ stock, worth $997,468. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,839
Previous 419,108 98.37%
Holding current value
$997,468
Previous $61.3 Million 98.19%
% of portfolio
0.02%
Previous 1.17%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $60 Million - $69 Million
-412,269 Reduced 98.37%
6,839 $1.11 Million
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $9.14 Million - $9.99 Million
63,302 Added 17.79%
419,108 $61.3 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $2.4 Million - $2.52 Million
-15,470 Reduced 4.17%
355,806 $56.3 Million
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $50.6 Million - $55.3 Million
347,786 Added 1480.57%
371,276 $58.2 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $97.9 Million - $110 Million
-628,594 Reduced 96.4%
23,490 $3.66 Million
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $95.9 Million - $103 Million
621,182 Added 2010.17%
652,084 $108 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $765,672 - $913,737
5,069 Added 19.62%
30,902 $4.79 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $1.03 Million - $1.16 Million
6,450 Added 33.28%
25,833 $4.56 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $7.07 Million - $7.87 Million
-43,818 Reduced 69.33%
19,383 $3.17 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $2.07 Million - $2.29 Million
12,326 Added 24.23%
63,201 $11.2 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $2.84 Million - $3.23 Million
17,966 Added 54.59%
50,875 $9.02 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $871,648 - $967,125
-5,590 Reduced 14.52%
32,909 $5.63 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $2.34 Million - $2.6 Million
14,498 Added 60.41%
38,499 $6.22 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $11 Million - $11.8 Million
-68,999 Reduced 74.19%
24,001 $4.13 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $7.75 Million - $8.63 Million
50,651 Added 119.6%
93,000 $15.3 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $63.7 Million - $73.2 Million
-464,951 Reduced 91.65%
42,349 $6.67 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $70 Million - $76.7 Million
498,598 Added 5729.69%
507,300 $75.5 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $3.61 Million - $4.36 Million
-28,057 Reduced 76.33%
8,702 $1.22 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $42 Million - $58.2 Million
-377,813 Reduced 91.13%
36,759 $4.82 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $52.3 Million - $60.1 Million
410,072 Added 9112.71%
414,572 $60.5 Million
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $3.12 Million - $3.5 Million
-24,600 Reduced 84.54%
4,500 $582,000
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $8.44 Million - $9.29 Million
-64,388 Reduced 68.87%
29,100 $4.05 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $5.97 Million - $6.64 Million
-47,497 Reduced 33.69%
93,488 $13.1 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $17.3 Million - $20.8 Million
140,985 New
140,985 $18.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ossiam Portfolio

Follow Ossiam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.